MONTREAL, April 05, 2018 -- DAVIDsTEA Inc. (Nasdaq:DTEA) today announced that its financial results for the fourth quarter of fiscal 2017 will be released after market close on Thursday, April 19, 2018. The Company will host a conference call at 4:30 p.m. Eastern Time that day to discuss the financial results.
Details of the Conference Call
Via telephone: 1-866-521-4909 or 647-427-2311
Via the internet at: www.davidstea.com, in the "investor relations" section.
An online archive of the webcast will be available within two hours of the conclusion of the call and will remain available for 30 days.
About DAVIDsTEA Inc.
DAVIDsTEA is a retailer of specialty tea, offering a differentiated selection of proprietary loose-leaf teas, pre-packaged teas, tea sachets and tea-related gifts, accessories and food and beverages, primarily through 236 company-operated DAVIDsTEA stores throughout Canada and the United States as of October 28, 2017, and its website, davidstea.com. The Company is headquartered in Montréal, Canada.
Investor Contact:
MaisonBrison Communications
Pierre Boucher
514-731-0000, x237
[email protected]


SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Anta Sports Expands Global Footprint With Strategic Puma Stake
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Amazon Explores AI Content Marketplace With Media Publishers
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



